Venetoclax (ABT-199)

Venetoclax (ABT-199)

Venetoclax (ABT-199) is a potent, selective, and orally bioavailable Bcl-2 inhibitor (Ki < 0.01 nM). It induces autophagy and inhibits Bcl-2-dependent cell growth and tumor xenografts. Venetoclax has shown antileukemic activity in refractory chronic lymphocytic leukemia and other Bcl-2-dependent cancers. Reagent grade, for research use only.

Molecular structure of the compound BP-43649
    • Unit
    • Price
    • Qty
    • 1 G
    • $150.00
    • 5 G
    • $450.00

Usually ships within 24 hours.

Would you like to inquire about custom quantity?
Inquire